Oseltamivir phosphate monotherapy ablates tumor neovascularization, growth, and metastasis in mouse model of human triple-negative breast adenocarcinoma

BACKGROUND: Triple-negative breast cancers (TNBCs) lack the estrogen, progesterone, and epidermal growth factor (EGF) receptor-2 (HER2/neu) receptors. Patients with TNBC have typical high grading, more frequent relapses, and exhibit poorer outcomes or prognosis compared with the other subtypes of br...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Breast Cancer (Dove Med Press)
Autors principals: Haxho, Fiona, Allison, Stephanie, Alghamdi, Farah, Brodhagen, Lacey, Kuta, Victoria EL, Abdulkhalek, Samar, Neufeld, Ronald J, Szewczuk, Myron R
Format: Artigo
Idioma:Inglês
Publicat: Dove Medical Press 2014
Matèries:
Original Research
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC4266271/
https://ncbi.nlm.nih.gov/pubmed/25525387
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/BCTT.S74663
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars